CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Reports First Quarter 2019 Financial

[China Jo-Jo Drugstores Reports First Quarter 2019 Financial Results HANGZHOU, China, Aug. 14, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare]

TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC Board of Directors Meeting Resolutions Hsinchu, Taiwan, R.O.C. – Aug. 14, 2018 – 1. Approved capital appropriations of approximately US$4,488.09 million for purposes including: 1) Construc]

By | 2018-08-16T07:40:38+00:00 August 14th, 2018|Categories: Chinese Stocks, SEC Original, TSM|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 10-Q:

[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]

TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC Board of Directors Meeting Resolutions Hsinchu, Taiwan, R.O.C. – Aug. 14, 2018 – 1. Approved capital appropriations of approximately US$4,488.09 million for purposes including: 1) Construc]

By | 2018-08-16T07:40:45+00:00 August 14th, 2018|Categories: Chinese Stocks, TSM, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)

[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores Reports First Quarter 2019 Financial Results HANGZHOU, China, Aug. 14, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare]

HPJ [Highpower International] 8-K: (Original Filing)

[Highpower International Reports Unaudited Second Quarter and First Half 2018 Financial Results SAN DIEGO, CALIFORNIA and SHENZHEN, China, August 13, 2018 /PRNewswire/ -- Highpower International, Inc. (NASDAQ: HPJ) ("Highpower" or the "Company"), a developer, manufacturer, and marketer of lithium ion]

HPJ [Highpower International] 10-Q:

[] [Number :0400000928-2018 Nian (Henggang) No. 00055 WORKING CAPITAL LOAN CONTRACT The Lender Person in charge: Duoping Yang Residence (address): East City Center Garden Street Shops 132, 132A, 133, Henggang Street, Longgang District, Shenzhen Zip Code: 518115 Borrower Legal representative: Dangyu P]

HPJ [Highpower International] 8-K: Highpower International Reports Unaudited Second Quarter and First

[Highpower International Reports Unaudited Second Quarter and First Half 2018 Financial Results SAN DIEGO, CALIFORNIA and SHENZHEN, China, August 13, 2018 /PRNewswire/ -- Highpower International, Inc. (NASDAQ: HPJ) ("Highpower" or the "Company"), a developer, manufacturer, and marketer of lithium ion]

CHU [CHINA UNICOM (HONG KONG)] 6-K: 1 Announcement dated August 10, 2018 in respect

[1 Announcement dated August 10, 2018 in respect of Change of Important Executive Positions. build-out • the Company’s ability to effectively sustain its growth and to achieve or enhance profitability; • • changes in the PRC telecommunications industry resulting from the issuance of licenses for tele]

By | 2018-08-14T03:35:35+00:00 August 13th, 2018|Categories: Chinese Stocks, CHU, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar